SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-23-058778
Filing Date
2023-05-11
Accepted
2023-05-11 08:00:40
Documents
64
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q carm-20230331x10q.htm   iXBRL 10-Q 1728379
2 EXHIBIT 10.18 carm-20230331xex10d18.htm EX-10.18 452278
3 EXHIBIT-31.1 carm-20230331xex31d1.htm EX-31.1 12115
4 EXHIBIT-31.2 carm-20230331xex31d2.htm EX-31.2 12140
5 EXHIBIT-32.1 carm-20230331xex32d1.htm EX-32.1 5769
6 EXHIBIT-32.2 carm-20230331xex32d2.htm EX-32.2 5792
  Complete submission text file 0001104659-23-058778.txt   6806214

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA carm-20230331.xsd EX-101.SCH 50084
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE carm-20230331_cal.xml EX-101.CAL 57532
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE carm-20230331_def.xml EX-101.DEF 121753
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE carm-20230331_lab.xml EX-101.LAB 462329
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE carm-20230331_pre.xml EX-101.PRE 307400
58 EXTRACTED XBRL INSTANCE DOCUMENT carm-20230331x10q_htm.xml XML 852656
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 23908918
SIC: 2834 Pharmaceutical Preparations